Acne Vulgaris Treatment Market, report categorizes the report by Product Type, Application and Geography. It provides information about – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025
Acne vulgaris is a common skin disease characterized by blackheads, whiteheads, papules, and pustules on the face, neck, back, and chest. It is commonly observed in adolescent population, however, can also affect adults. Depending on its severity, acne may be segmented into mild, moderate or severe. It is caused due to excess oil produced in sebaceous glands under skin, which becomes plugged and inflated. Female patient with polycystic ovarian syndrome and even hormonal disorders such as excess androgen production may suffer from acne as well. People with acne vulgaris are usually characterized by social withdrawal, low self-esteem, and depression with suicidal tendencies.
To understand Research Methodology, please click: https://www.coherentmarketinsights.com/insight/request-sample/1260
U.S. is expected to be the largest market for acne vulgaris treatment products over the forecast period
According to a study published in the British Journal of Dermatology in 2015, 9.4% of global population was estimated to be affected by acne. Moreover, globally, acne is the eight most prevalent disease. The U.S. is the largest market for acne vulgaris treatment products. According to study by National Institute of Health (NIH), in 2013, over US$ 3 Billion was spent for treating acne vulgaris in the U.S. In 2014, according to American Academy of Dermatology, the number of acne vulgaris patient aged 25 years and above, especially women, is rising significantly. Furthermore, low awareness regarding the factors causing acne is another factor leading to increasing prevalence acne vulgaris.
Treatment for acne on an average lasts for two years, therefore companies capitalize on this and earn sustainable revenue from acne treatment products. Majority of the population suffering from acne prefer OTC products as first line therapy. However, some have to visit dermatologist to cure acne vulgaris on account of ineffective result from OTC products.
Acne Vulgaris Treatment Market Taxonomy:
On the basis of product type, the global acne vulgaris treatment market is segmented into:
Medications
Benzoyl peroxides
Retinoids
Systemic and topical Antibiotics
Hormonal Agents
Others (Salicylic Acid, Azelic, Dapsone, and Alternative therapy)
Devices
Laser devices
Heat extraction devices
Others
Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1260
India is expected to have largest pool of population in the age group 15–25 years by 2020. This, in turn, makes it a highly lucrative market for acne vulgaris treatment products. India also has high glycemic index diet, which is further expected to aid in growth of the market over the forecast period. Manufacturers are also focusing on developing products for scarring, resulting from acne. New treatments such as cosmetic (laser, chemical peel, and photodynamic therapy) and surgical procedures are been developed for treatment of scarring. Increasing consumer inclination towards alternative way to treat acne vulgaris such as herbal therapy (tee tree oil), owing to low side effects is another factor expected to aid in growth of the acne vulgaris treatment market. Home-based devices for acne removal such as revive light therapy and neutrogena light therapy are gaining significant traction over the forecast period.
Key players in the acne vulgaris treatment market are focusing on collaboration, acquisition, and new product development strategies in order to enhance their product offerings and sustaining their position in the market. For instance, in 2017, L’Oréal — a global beauty company — signed an agreement with Valeant Pharmaceuticals International, Inc. to acquire its skin care brands portfolio which includes anti-acne brand AcneFree at US$1.3 billion. Also, in November 2017 Novan Inc., announced its plans to conduct phase three clinical trial for its new anti-acne molecule. Novan has unique nitric oxide technology, Nitrici, through which a timed release of nitric oxide from chemical entity is possible. This is beneficial as nitric oxide has natural ability to revitalize tissue, kill invading microorganisms, prevent clotting, regulate inflammation, and even aid in removing cancer cells. Moreover, in 2017, Valeant Pharmaceuticals International, Inc. signed an agreement with Haitong International Zhonghua Finance Acquisition Fund I, L.P, to sell its Obagi Medical Products business for US$ 190 million in cash. Obagi Medical Products have high presence in acne treatment products market.
Key players in the global acne vulgaris treatment market are Allergan plc, GlaxoSmithKline plc, Valeant Pharmaceutical International Inc., F.Hoffmann-La Roche AG, Mylan, N.V., Bayer AG, Janssen Pharma Inc., Galderma Inc., Pfizer Inc., and Novan Inc.
Contact Us:
Mr. ShahCoherent Market Insights1001 4th Ave, #3200Seattle, WA 98154Tel: +1-206-701-6702Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com/
Aspergillosis Treatment Market Opportunity Analysis, 2018-2026
Patent expiration of branded products and drug resistance to antifungal medications are the factors restraining growth of the market.Measles Mumps and Rubella (MMR) Vaccines Market Opportunity Analysis, 2018 – 2026
Vaccine manufacturers are focusing on partnering with organizations such WHO, UNICEF, and GAVI Alliance to improve their vaccination programs, in order to reach the maximum population to offer vaccines.PoC Platform & Technology Market to Surpass US$ 45.4 Billion by 2025
The global POC platform & technology market was valued at US$ 21,370.3 Million in 2016 and is expected to exhibit a robust CAGR of 8.9% over the forecast period (2017 – 2025).